|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis0 S/ _- k |$ ?, F3 F/ H) {
was to close its brain research facility in Basel, Switzerland,
: R8 Z% z" S3 `* ?3 e7 C5 Z% bthe story noted that this move closely followed similar cuts3 O; K- h- {! t& e4 u
by rival pharmaceutical firms. As a report from the European College
% K/ e- z# S) cof Neuropsychopharmacology
( P1 ^; ]! S$ y T Shad warned a few months earlier, the% A. @6 y# o# n8 x
abandonment of research into new psychiatric drugs by AstraZeneca,! I: f4 J4 K7 t2 }1 [( l( i: c
GlaxoSmithKline# H% _* v0 Z0 _2 Z; N( ~0 d: U; E
and others meant that “withdrawal of research
' m- R6 s) G: p6 ~0 B5 |resources is a withdrawal of hope for patients and their families”." ~" u9 B# W ^$ \* L' h
9 J7 R8 Y; R6 D2 k# R9 \
( I( X; D; [0 [1 M. Z4 D回复有免费下载链接: B1 L% |5 ~/ q' @9 K3 P* O6 ]( b
" O T( W, F( `. `8 A" P- c1 v8 n4 } |
-
总评分: 包包 + 20
查看全部评分
|